TTK Healthcare Ltd
₹ 898
-1.12%
10 Jun
1:48 p.m.
- Market Cap ₹ 1,247 Cr.
- Current Price ₹ 898
- High / Low ₹ 1,402 / 735
- Stock P/E 18.1
- Book Value ₹ 789
- Dividend Yield 1.11 %
- ROCE 8.04 %
- ROE 6.32 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 1.16 times its book value
- Company has been maintaining a healthy dividend payout of 20.4%
Cons
- Company has a low return on equity of 6.55% over last 3 years.
- Earnings include an other income of Rs.68.1 Cr.
- Working capital days have increased from 86.1 days to 161 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 483 | 519 | 528 | 578 | 628 | 646 | 476 | 599 | 725 | 753 | 801 | 857 | |
| 453 | 478 | 489 | 535 | 578 | 617 | 457 | 577 | 694 | 715 | 767 | 831 | |
| Operating Profit | 30 | 40 | 38 | 43 | 50 | 28 | 19 | 22 | 31 | 37 | 35 | 26 |
| OPM % | 6% | 8% | 7% | 7% | 8% | 4% | 4% | 4% | 4% | 5% | 4% | 3% |
| 7 | 6 | 6 | 8 | 8 | 9 | 28 | 42 | 643 | 63 | 85 | 68 | |
| Interest | 4 | 3 | 3 | 5 | 3 | 3 | 2 | 3 | 5 | 3 | 3 | 3 |
| Depreciation | 6 | 7 | 12 | 15 | 15 | 14 | 13 | 13 | 13 | 13 | 8 | 9 |
| Profit before tax | 26 | 36 | 29 | 30 | 39 | 19 | 32 | 48 | 657 | 84 | 108 | 83 |
| Tax % | 39% | 36% | 36% | 40% | 38% | 37% | -44% | 13% | 3% | 25% | 25% | 20% |
| 16 | 23 | 19 | 18 | 24 | 12 | 46 | 42 | 640 | 63 | 82 | 66 | |
| EPS in Rs | 20.81 | 29.19 | 24.13 | 12.86 | 17.25 | 8.72 | 32.87 | 29.43 | 452.72 | 44.47 | 57.79 | 46.48 |
| Dividend Payout % | 22% | 17% | 21% | 39% | 29% | 34% | 18% | 34% | 2% | 22% | 17% | 22% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 12% |
| 3 Years: | 6% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 11% |
| 3 Years: | -52% |
| TTM: | -3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 6% |
| 3 Years: | -11% |
| 1 Year: | -31% |
| Return on Equity | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 22% |
| 3 Years: | 7% |
| Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 110 | 128 | 150 | 219 | 237 | 235 | 281 | 316 | 939 | 987 | 1,051 | 1,101 |
| 42 | 38 | 23 | 47 | 29 | 30 | 19 | 22 | 27 | 23 | 24 | 24 | |
| 115 | 128 | 104 | 127 | 136 | 152 | 180 | 207 | 189 | 183 | 192 | 190 | |
| Total Liabilities | 275 | 303 | 285 | 407 | 416 | 431 | 494 | 559 | 1,170 | 1,206 | 1,281 | 1,329 |
| 52 | 106 | 99 | 110 | 98 | 89 | 85 | 80 | 71 | 75 | 81 | 73 | |
| CWIP | 46 | 1 | 0 | 1 | 2 | 9 | 0 | 0 | 3 | 1 | 0 | 1 |
| Investments | 0 | 10 | 9 | 9 | 13 | 9 | 13 | 15 | 13 | 13 | 11 | 9 |
| 177 | 185 | 177 | 288 | 304 | 325 | 395 | 463 | 1,083 | 1,118 | 1,189 | 1,246 | |
| Total Assets | 275 | 303 | 285 | 407 | 416 | 431 | 494 | 559 | 1,170 | 1,206 | 1,281 | 1,329 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39 | 37 | 18 | 25 | 17 | 20 | 96 | 45 | -25 | -5 | -4 | -21 | |
| -49 | -27 | 5 | -22 | 10 | -13 | -77 | -30 | 32 | 28 | 20 | 52 | |
| 3 | -11 | -23 | -7 | -31 | -10 | -17 | -10 | -12 | -22 | -18 | -18 | |
| Net Cash Flow | -7 | -0 | 0 | -4 | -4 | -4 | 2 | 5 | -6 | 2 | -2 | 13 |
| Free Cash Flow | -10 | 21 | 12 | 21 | 13 | 8 | 95 | 42 | -36 | -15 | 6 | -25 |
| CFO/OP | 176% | 122% | 67% | 84% | 62% | 108% | 391% | 248% | -28% | 54% | 68% | -3% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 34 | 33 | 24 | 35 | 47 | 43 | 46 | 33 | 46 | 42 | 41 | 47 |
| Inventory Days | 62 | 66 | 65 | 80 | 77 | 101 | 123 | 102 | 89 | 105 | 107 | 98 |
| Days Payable | 50 | 53 | 100 | 130 | 101 | 121 | 170 | 134 | 116 | 110 | 106 | 83 |
| Cash Conversion Cycle | 46 | 46 | -11 | -16 | 22 | 23 | -2 | 1 | 19 | 36 | 43 | 63 |
| Working Capital Days | -31 | -38 | -24 | -30 | -6 | -3 | -32 | -28 | 4 | 49 | 48 | 161 |
| ROCE % | 20% | 23% | 18% | 15% | 15% | 8% | 6% | 8% | 10% | 9% | 9% | 8% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Employee Count Number |
|
|||||||||
| TTK Chitra Heart Valve Volume Growth % |
||||||||||
| Woodward's Gripe Water Volume Growth % |
||||||||||
| Number of Distributors / Dealers Number |
||||||||||
| Skore Condoms Volume Growth % |
||||||||||
| Foods Capacity Utilization (Jaipur Plant) % |
||||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
- Record Date 3 Jun
-
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
1 Jun - TTK Healthcare paid Rs.9,93,320 penalty on customs duty differential on June 01, 2026.
- Outcome Of Board Meeting 30 May
- Outcome Of Board Meeting 30 May
-
Announcement under Regulation 30 (LODR)-Dividend Updates
30 May - TTK Healthcare approved FY26 audited results, recommended Rs.10 dividend, reappointed Executive Chairman, and fixed AGM on July 24, 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Sep 2016TranscriptAI SummaryPPT
Business Segments
1. Consumer Products : The company markets and distributes products that transcend categories; baby care (Woodward’s Gripe Water), personal care (Eva Deodrants), home care- room & air fresheners (Good Home ), and sexual wellness (Skore). [1] The Woodward's Gripe Water is one of the oldest FMCG brands worldwide and is a market leader in the Indian colic market. It has been marketed in India since 1928. It has a distribution network of 27 warehouses, 2,600+ distributors, 650+ frontline sales teams, and a reach of ~4 lakh outlets across India. [2]